Hillenbrand, Inc. (HI) announced that it has completed the previously announced sale of its majority interest in the Milacron injection molding and extrusion business (or Milacron) to Bain Capital for $287 million. This move aligns with Hillenbrand's ongoing portfolio transformation efforts to boost its overall margins by focusing on less cyclical and higher growth opportunities.HI to Lower Debt Utilizing Sale ProceedsThe Milacron injection molding and extrusion business came under Hillenbrand’s portfolio f ...